about
New and emerging treatments for symptomatic tardive dyskinesiaAntipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanismsAntipsychotic dosing: found in translationOlanzapine treatment of adolescent rats causes enduring specific memory impairments and alters cortical development and function.Parametric studies of antipsychotic-induced sensitization in the conditioned avoidance response model: roles of number of drug exposure, drug dose, and test-retest interval.The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.Olanzapine sensitization and clozapine tolerance: from adolescence to adulthood in the conditioned avoidance response modelDrug information update. Unconventional treatment strategies for schizophrenia: polypharmacy and heroic dosing.Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthoodDo all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study.Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and gender.Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.Future viable models of psychiatry drug discovery in pharma.Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.A systematic review of antipsychotic drug effects on human gene expression related to risk factors for cardiovascular disease.Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.Use of siRNA in knocking down of dopamine receptors, a possible therapeutic option in neuropsychiatric disorders.Clozapine administration in clinical practice: once-daily versus divided dosing.Targeted intermittent treatment in chronic schizophreniaAvoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis.Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia.Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function.[Long-acting injectable antipsychotics. Overview and advice for daily routine care].
P2860
Q24599912-7CBC38F3-816E-42D6-B0F5-602C0CDE5988Q26745506-6CED41D2-DE84-43F6-95BD-2FD3113DA144Q26863343-33ACB558-20D4-4386-ADEA-198B01ABD862Q27313333-6982437D-AC33-44BD-A0EF-2C1ED980897BQ30390855-55AD8DAC-C408-4D26-A258-8C37C895F2DCQ30437188-9B84A1E0-A379-46BB-AD8B-4A092C8C9E2EQ30443699-7F23A9F3-6453-4936-A1C2-990B929BB89AQ33747710-048973FE-CAAC-47E9-B301-BFF1F4B3E50EQ34053684-F5063826-079C-4085-87DD-269DEF1C388CQ34254903-3BB90834-7975-4A9A-B268-C3E60D3B2A21Q34703195-248ED9D4-F138-49A3-A3BB-646211BE191AQ35075344-74DD0101-98CF-4EF6-8E27-B3E56A939BA9Q36590407-057E0D9B-E1C3-4A68-B542-43BDA27BF9EDQ38080006-C353385E-4FE8-4FD5-AF57-9C2EAAEF1CBEQ38086645-1E64BADD-AF29-44C8-BE54-17C2BA5C79B5Q38194900-C539E252-350A-4360-BFA6-82680F088EAEQ38239613-F324CC89-5200-4E3D-9020-901B83023D9BQ39531863-8B83A8F8-A1D0-44F2-A425-A89D65B8A016Q39763748-2F33A300-8724-4B7C-8630-D04E096415B3Q41156644-E278D815-070A-4AE7-95F3-4781B103CF59Q41837878-ECB1B894-6C51-4DF1-BFBD-91FAD49ECB5DQ42380356-D5DE1338-7C21-4BAD-B15F-88B63DA22A29Q45369595-884C2D5E-4144-4B4F-9D96-685971546EFFQ52882243-FA02AC6B-6F89-4F03-A431-97B734E95896
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Antipsychotic dosing: how much but also how often?
@ast
Antipsychotic dosing: how much but also how often?
@en
Antipsychotic dosing: how much but also how often?
@nl
type
label
Antipsychotic dosing: how much but also how often?
@ast
Antipsychotic dosing: how much but also how often?
@en
Antipsychotic dosing: how much but also how often?
@nl
prefLabel
Antipsychotic dosing: how much but also how often?
@ast
Antipsychotic dosing: how much but also how often?
@en
Antipsychotic dosing: how much but also how often?
@nl
P2860
P356
P1476
Antipsychotic dosing: how much but also how often?
@en
P2860
P304
P356
10.1093/SCHBUL/SBQ083
P407
P577
2010-07-21T00:00:00Z